Article in Press Analysis
Genome-wide association study of social isolation in 63,497 Japanese individuals from the general population
This groundbreaking study is the first genome-wide association study (GWAS) of social isolation in an East Asian population, identifying novel genetic loci (rs10736933 near ACADSB and HMX3, and rs1778366 near LINC02315 and LRFN5) associated with social isolation. These findings provide critical insights into the biological mechanisms underlying social isolation and its links to neurobehavioral and psychiatric disorders, enabling personalized prevention and intervention strategies. The study utilized a validated questionnaire (LSNS-6) in a large cohort of 63,497 Japanese individuals.
Executive Impact: Key Metrics & Breakthroughs
This research provides critical insights into the genetic underpinnings of social isolation, laying the groundwork for precision interventions and improved public health outcomes.
0
Individuals Studied
0
Novel Genetic Loci Identified
0
Heritability Range for Social Isolation
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Social isolation is a significant public health issue with adverse health outcomes and is linked to psychiatric disorders. Previous GWASs have focused on Western populations and often lacked validated questionnaires. This study addresses these gaps by conducting the first GWAS in an East Asian population using a validated measure.
63,497
Japanese individuals in the general population included in the study
| Feature | Previous UK Biobank Studies | Current Japanese Study |
|---|---|---|
| Population | Primarily European | East Asian (Japanese) |
| Questionnaire Validation | Self-report, often lacking thorough validation | Lubben Social Network Scale (LSNS-6), validated |
| Novelty of Loci | Identified >30 associations, different loci reported across studies | Identified novel loci (ACADSB, HMX3, LINC02315, LRFN5) not replicated in UK Biobank studies |
| Prevalence of Social Isolation | Lower than Japan | Higher than UK |
The study utilized data from the Tohoku Medical Megabank Community-Based Cohort Study (TMM CommCohort Study), which recruited participants between 2013 and 2016. Genotyping was performed using the Affymetrix Axiom Japonica Array (v2), and social isolation was assessed via the LSNS-6, defining isolation by specific score thresholds. GWASs were conducted using a generalized linear mixed model.
Enterprise Process Flow
Participant Recruitment (2013-2016)
→
LSNS-6 Data Collection
→
Genotyping (Affymetrix Axiom Japonica Array)
→
Quality Control & Imputation
→
GWAS using Generalized Linear Mixed Model
→
Meta-analysis (METAL)
→
Annotation & Heritability Estimation
LSNS-6
Validated questionnaire used to assess social isolation
The study identified two significant genetic loci: rs10736933 (near ACADSB and HMX3) for total social isolation, and rs1778366 (near LINC02315 and LRFN5) for friend subscale social isolation. These genes are linked to metabolic processes and synaptic development, suggesting biological underpinnings. Heritability estimates for social isolation ranged from 2.4% to 4.0%.
rs10736933
Significant variant for total social isolation (near ACADSB and HMX3)
rs1778366
Significant variant for friend subscale social isolation (near LINC02315 and LRFN5)
Genetic Links to Neurobehavioral Phenotypes
Variants near LRFN5 are associated with numerous neurobehavioral and psychiatric phenotypes, including well-being, neuroticism, educational attainment, major depressive disorder, generalized anxiety disorder, and autism. The association of rs1778366 with depressive symptoms in this study further strengthens the link between genetic predispositions to social isolation and broader psychiatric etiologies. This implies that understanding these genetic markers could offer novel targets for intervention in related disorders.
Impact: Unlocking personalized prevention and intervention strategies for social isolation and psychiatric disorders by targeting identified genetic pathways.
Advanced ROI Calculator
Estimate the potential return on investment for implementing AI-driven solutions informed by genomic insights within your enterprise.
Estimated Annual Savings
$0
Annual Hours Reclaimed
0
Your Implementation Roadmap
A strategic phased approach to integrate these insights into your enterprise, ensuring a smooth transition and maximum impact.
Phase 1: Genomic Data Integration
Integrate existing patient genomic data with social determinants of health (SDOH) to identify at-risk populations for social isolation. Develop a robust data pipeline for secure and compliant data handling.
Phase 2: Predictive Modeling & Risk Stratification
Utilize identified genetic loci (e.g., ACADSB, HMX3, LINC02315, LRFN5) to build predictive models for social isolation risk. Stratify patient populations into low, medium, and high-risk groups to guide targeted interventions.
Phase 3: Personalized Intervention Design
Design and pilot personalized intervention programs based on genetic predisposition and identified risk factors. Examples include tailored social prescribing, community engagement programs, or behavioral therapy referrals. Focus on culturally sensitive approaches for East Asian populations.
Phase 4: Outcome Monitoring & Model Refinement
Implement a continuous monitoring system to track the effectiveness of interventions and patient outcomes. Use real-world data to refine predictive models and optimize intervention strategies, ensuring iterative improvement.
Ready to Transform Your Enterprise with AI?
Book a complimentary 30-minute strategy session with our AI experts to explore how these insights can be tailored to your organization's unique needs.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat